Chronic Obstructive Pulmonary Disease is the most common form of pulmonary disease and accounts for nearly 60% of all pulmonary disorders. With the increasing incidence of diseases such as emphysema and chronic bronchitis, it has become imperative for the healthcare industry to look at new treatments and prevention strategies to improve quality of life. The outlook for improvement is promising but challenging due to the large number of patients that require successful therapy to control or reverse the disease. The other two major areas of focus for Pulmonary Drugs include acute and chronic respiratory conditions. Respiratory Depression is a very prevalent condition affecting millions of people across the globe. Due to this fact, it is estimated that more than 30 million people in the USA alone are affected by Respiratory Depression every year. Acute Respiratory Depression is another very common respiratory condition that is responsible for inducing sleepless nights, extreme stress, depression, anxiety, and irritability. On the other hand, Chronic Respiratory Depression can also lead to serious complications such as hallucinations, suicidal thoughts, and even physical health deterioration.
Tags
Blogs